Skip to content
Toggle Navigation
ABOUT
About Us
Leadership & Board of Directors
Expanded Access
TECHNOLOGY
STERIWAVE
NEWS
INVESTORS
Share Price
Regulatory News
Email Alerts
Reports & Documentation
Corporate Governance
AIM Rule 26
Investor Contacts
CONTACT US
NEWS & ARTICLES
Web Master
2024-12-17T17:20:03-08:00
News
Ondine and Mid Yorks Win Excellence in Healthcare Partnership Award
Search for:
Top Categories
Toggle Navigation
AMR
COVID-19
Infection Control
Steriwave
Research
Events
Ondine’s photodisinfection kills ESKAPE pathogens
September 7, 2022
Ondine reports successful US Phase 2 trial data
September 6, 2022
Nature publication: Ondine’s therapy suppresses SARS2 in COVID-19 patients
August 31, 2022
Ondine completes enrollment for US Phase II nasal photodisinfection trial
August 8, 2022
Successful SARS-CoV-2 trial with Ondine’s nasal photodisinfection
July 19, 2022
WHO calls for new innovations to tackle antimicrobial resistance crisis
July 6, 2022
Photodisinfection effective against SARS-CoV-2
April 5, 2022
First patients treated in US Phase 2 trial
February 7, 2022
Photodisinfection could be game-changer in fight against resistance
January 21, 2022
Previous
11
12
13
Next
Load More Posts
For Media Information
Simon Vane Percy
+44 (0) 1737 82180
simon@vanepercy.com
Amanda Bernard
+ 44 (0) 77763 73269
amanda@vanepercy.com
Page load link
Go to Top